Aspergillus Tracheobronchitis Report of 8 Cases and Review of the Literature

被引:90
作者
Fernandez-Ruiz, Mario [1 ]
Tiago Silva, Jose [3 ]
San-Juan, Rafael
de Dios, Begona
Garcia-Lujan, Ricardo [2 ]
Lopez-Medrano, Francisco
Lizasoain, Manuel
Maria Aguado, Jose
机构
[1] Hosp Univ 12 Octubre, Ctr Actividades Ambulatorias, Infect Dis Unit, Inst Invest Hosp 12 Octubre I 12, Madrid 28041, Spain
[2] Hosp Univ 12 Octubre, Dept Pneumol, Madrid 28041, Spain
[3] Complejo Hosp Univ Badajoz, Hosp Infanta Cristina, Dept Internal Med, Badajoz, Spain
关键词
NECROTIZING BRONCHIAL ASPERGILLOSIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; LUNG-TRANSPLANT RECIPIENTS; INVASIVE PULMONARY ASPERGILLOSIS; BONE-MARROW-TRANSPLANTATION; ACUTE RESPIRATORY-FAILURE; ACUTE AIRWAY-OBSTRUCTION; IMMUNOCOMPROMISED PATIENT; AMPHOTERICIN-B; ULCERATIVE TRACHEOBRONCHITIS;
D O I
10.1097/MD.0b013e31826c2ccf
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aspergillus tracheobronchitis (AT) is an infrequent but severe form of invasive pulmonary aspergillosis in which the fungal infection is entirely or predominantly confined to the tracheobronchial tree. We reviewed 8 cases of AT diagnosed in our tertiary care center during an 18-year period, as well as 148 cases previously reported in the English literature from 1985 to July 2011. The demographic, clinical, imaging, bronchoscopic, and outcome characteristics of every eligible patient were excerpted, and predictors of inhospital mortality were identified by logistic regression. Solid organ transplantation (SOT) (44.2%), hematologic malignancy (21.2%), neutropenia (18.7%), and chronic obstructive pulmonary disease (15.4%) were the most common underlying conditions reported. Most cases occurred in patients receiving long-term corticosteroid treatment (71.8%) or chemotherapy (25.0%). Fever and respiratory complaints (cough, dyspnea, stridor, or wheezing) were the most frequent symptoms; one-third of patients developed acute respiratory distress at presentation, and 15.1% were asymptomatic at the time of diagnosis. Initial imaging studies were not informative in 47.4% of the cases. Aspergillus fumigatus was the predominant species (74.4%). The pseudomembranous form was the most commonly observed (31.9% of cases) and was more frequent in neutropenic patients (p = 0.007), whereas ulcerative AT (31.2%) was associated with SOT (p = 0.001). The most frequent antifungal monotherapy regimens were amphotericin B deoxycholate (23.1%) and itraconazole (18.6%), whereas combined therapy was administered in 35.9% of the cases. Overall inhospital mortality was 39.1%, with neutropenia (odds ratio [OR], 20.47; p < 0.001) and acute respiratory distress at presentation (OR, 9.54; p = 0.002) as independent prognostic factors. Our pooled analysis of the literature shows that AT remains a rare opportunistic infection with a nonspecific presentation and a variable course depending on the nature of the predisposing factor.
引用
收藏
页码:261 / 273
页数:13
相关论文
共 76 条
[1]  
Achan V, 1996, CLIN INTENSIVE CARE, V7, P102
[2]   Pseudomembranous necrotizing bronchial aspergillosis [J].
Ahn, MI ;
Park, SH ;
Kim, JA ;
Kwon, MS ;
Park, YH .
BRITISH JOURNAL OF RADIOLOGY, 2000, 73 (865) :73-75
[3]   Nodular invasive tracheobronchitis due to Aspergillus in a patient with systemic lupus erythematosus [J].
Angelotti, T ;
Krishna, G ;
Scott, J ;
Berry, G ;
Weinacker, A .
LUPUS, 2002, 11 (05) :325-328
[4]   Simultaneous obstructing and pseudomembranous necrotizing tracheobronchitis due to Aspergillus flavus [J].
Arriero, JM ;
Chiner, E ;
Marco, J ;
Mayol, MJ ;
Serna, M .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) :1464-1465
[5]   Aspergillus laryngotracheobronchial infection in a 6-year-old girl following bone marrow transplantation [J].
Barnes, C ;
Berkowitz, R ;
Curtis, N ;
Waters, K .
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2001, 59 (01) :59-62
[6]   ACUTE AIRWAY-OBSTRUCTION DUE TO NECROTIZING TRACHEO-BRONCHIAL ASPERGILLOSIS IN IMMUNOCOMPROMISED PATIENTS - A NEW CLINICAL ENTITY [J].
BERLINGER, NT ;
FREEMAN, TJ .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1989, 98 (09) :718-720
[7]   SUCCESSFUL TREATMENT OF INVASIVE BRONCHIAL ASPERGILLOSIS AFTER SINGLE-LUNG TRANSPLANTATION [J].
BIGGS, VJ ;
DUMMER, S ;
HOLSINGER, FC ;
LOYD, JE ;
CHRISTMAN, BW ;
FRIST, WH .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (01) :123-124
[8]  
Birsan T, 1998, J HEART LUNG TRANSPL, V17, P437
[9]   Topical amphotericin B application in severe bronchial aspergillosis after lung transplantation:: Report of experiences in 3 cases [J].
Boettcher, H ;
Bewig, B ;
Hirt, SW ;
Möller, F ;
Cremer, J .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (12) :1224-1227
[10]   Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF [J].
Boots, RJ ;
Paterson, DL ;
Allworth, AM ;
Faoagali, JL .
THORAX, 1999, 54 (11) :1047-1049